Long-term Survival Outcomes of 'Low Risk' Ductal Carcinoma in situ from a Territory-wide Cancer Registry

Co, M; Ngan, RKC; Mang, OWK; Tam, AHP; Wong, KH; Kwong, A

Kwong, A (corresponding author), Queen Mary Hosp, K1401, Hong Kong, Peoples R China.

CLINICAL ONCOLOGY, 2021; 33 (1): 40

Abstract

Aims: The LORIS trial is an ongoing phase III clinical trial on low risk ductal carcinoma in situ (DCIS). DCIS patients aged >= 46 years with scree......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索